Fludarabine: A New Agent With Major Activity Against Chronic Lymphocytic Leukemia von Keating, M.J., Kantarjian, H., Talpaz, M., Redman, J., Koller, C., Barlogie, B., Velasquez, W., Plunkett, W., Freireich, E.J, McCredie, K.B.

Volltext

Clinical Investigation of Human Alpha Interferon in Chronic Myelogenous Leukemia von Talpaz, Moshe, M, Hagop, Kantarjian, McCredie, Kenneth B., Keating, Michael J., Trujillo, Jose, Gutterman, Jordan

Volltext

Response to salvage therapy and survival after relapse in acute myelogenous leukemia von Keating, M J, Kantarjian, H, Smith, T L, Estey, E, Walters, R, Andersson, B, Beran, M, McCredie, K B, Freireich, E J

Volltext

Fludarabine: a new agent with marked cytoreductive activity in untreated chronic lymphocytic leukemia von Keating, M J, Kantarjian, H, O'Brien, S, Koller, C, Talpaz, M, Schachner, J, Childs, C C, Freireich, E J, McCredie, K B

Volltext

TREATMENT OF HAIRY-CELL LEUKEMIA WITH 2-CHLORODEOXYADENOSINE (2-CDA) von ESTEY, EH, KURZROCK, R, KANTARJIAN, HM, OBRIEN, SM, MCCREDIE, KB, BERAN, M, KOLLER, C, KEATING, MJ, HIRSCHGINSBERG, C, HUH, YO, STASS, S, FREIREICH, EJ

Volltext

Therapy-related leukemia and myelodysplastic syndrome: clinical, cytogenetic, and prognostic features von Kantarjian, H M, Keating, M J, Walters, R S, Smith, T L, Cork, A, McCredie, K B, Freireich, E J

Volltext

Leukocyte Interferon-Induced Myeloid Cytoreduction in Chronic Myelogenous Leukemia von Talpaz, Moshe, McCredie, Kenneth B., Mavligit, Giora M., Gutterman, Jordan U.

Volltext

Characteristics of accelerated disease in chronic myelogenous leukemia von Kantarjian, Hagop M., Dixon, Dennis, Keating, Michael J., Talpaz, Moshe, Walters, Ronald S., McCredie, Kenneth B., Freireich, Emil J

Volltext

HL-60 Cell Line Was Derived From a Patient With FAB-M2 and Not FAB-M3 von Dalton Jr, Willard T., Ahearn, Michael J., McCredie, Kenneth B., Freireich, Emil J, Stass, Sanford A., Trujillo, Jose M.

Volltext

Proposal for a simple synthesis prognostic staging system in chronic myelogenous leukemia von Kantarjian, Hagop M., Keating, Michael J., Smith, Terry L., Talpaz, Moshe, McCredie, Kenneth B.

Volltext

Identification of Risk Groups for Development of Central Nervous System Leukemia in Adults With Acute Lymphocytic Leukemia von Kantarjian, Hagop M., Walters, Ronald S., Smith, Terry L., Keating, Michael J., Barlogie, Bart, McCredie, Kenneth B., Freireich, Emil J.

Volltext

Amphotericin B or ketoconazole therapy of fungal infections in neutropenic cancer patients von FAINSTEIN, V, BODEY, G. P, ELTING, L, MAKSYMIUK, A, KEATING, M, MCCREDIE, K. B

Volltext

Chronic myelogenous leukemia--progress at the M. D. Anderson Cancer Center over the past two decades and future directions: first Emil J Freireich Award Lecture von Kantarjian, H M, Talpaz, M, O'Brien, S, Kurzrock, R, Gutterman, J, Keating, M J, McCredie, K B, Freireich, E J

Volltext

Chronic Myelogenous Leukemia: A Multivariate Analysis of the Associations of Patient Characteristics and Therapy With Survival von Kantarjian, Hagop M., Smith, Terry L., McCredie, Kenneth B., Keating, Michael J., Walters, Ronald S., Talpaz, Moshe, Hester, Jeane P., Bligham, Geert, Gehan, Edmund, Freireich, Emil J.

Volltext

Fatal pulmonary failure complicating high‐dose cytosine arabinoside therapy in acute leukemia von Andersson, Borje S., Yee, Cassian, Keating, Michael J., McCredie, Kenneth B., Luna, Mario A., Hui, Kathleen K.

Volltext

The characteristics and outcome of patients with late relapse acute myelogenous leukemia von Kantarjian, H M, Keating, M J, Walters, R S, McCredie, K B, Freireich, E J

Volltext

Intensive combination chemotherapy (ROAP 10) and splenectomy in the management of chronic myelogenous leukemia von Kantarjian, H M, Vellekoop, L, McCredie, K B, Keating, M J, Hester, J, Smith, T, Barlogie, B, Trujillo, J, Freireich, E J

Volltext

Toward a clinically relevant cytogenetic classification of acute myelogenous leukemia von Keating, Michael J., Cork, Ann, Broach, Yvonne, Smith, Terry, Walters, Ronald S., McCredie, Kenneth B., Trujillo, Jose, Freireich, Emil J

Volltext

High-dose cytosine arabinoside: treatment and cellular pharmacology of chronic myelogenous leukemia blast crisis von Iacoboni, S J, Plunkett, W, Kantarjian, H M, Estey, E, Keating, M J, McCredie, K B, Freireich, E J

Volltext

Antileukemic Effect of Recombinant Tumor Necrosis Factor α in vitro and Its Modulation by α and γ Interferons von Beran, Miloslav, McCredie, Kenneth B., Keating, Michael J., Gutterman, Jordan U.

Volltext